New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Danaher Corporation has announced a collaboration with AstraZeneca for diagnostic tools and tests development and ...

England has rolled out a new liquid biopsy test intended to fast-track lung cancer patients to receive targeted therapy.

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...

Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.

Illumina is expanding access to its oncology range of IVD tests, as its TruSight Oncology Comprehensive IVD is now covered ...

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery system to be used in adult cholecystectomies.

Zylox-Tonbridge Medical Technology has received regulatory approval for its ZYLOX Unicorn vascular closure device (VCD) in ...